Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy

Jacquelyn Russell, Melisa L. Wong, Lynda Mackin, Steven M. Paul, Bruce A. Cooper, Marilyn Hammer, Yvette P. Conley, Fay Wright, Jon D. Levine, Christine Miaskowski

Research output: Contribution to journalArticle

Abstract

Context: Patients with lung cancer who undergo chemotherapy (CTX) experience multiple symptoms. Evaluation of how these symptoms cluster together and how these symptom clusters change over time are salient questions in symptom clusters research. Objectives: The purposes of this analysis, in a sample of patients with lung cancer (n = 145) who were receiving CTX, were to 1) evaluate for differences in the number and types of symptom clusters at three time points (i.e., before their next cycle of CTX, the week after CTX, and two weeks after CTX) using ratings of symptom occurrence and severity and 2) evaluate for changes in these symptom clusters over time. Methods: At each assessment, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, six distinct symptom clusters were identified; however, only three of these clusters (i.e., lung cancer specific, psychological, nutritional) were relatively stable across both dimensions and across time. Two additional clusters varied by time but not by symptom dimension (i.e., epithelial/gastrointestinal and epithelial). A sickness behavior cluster was identified at each assessment with the exception of the week before CTX using only the severity dimension. Conclusion: Findings provide insights into the most common symptom clusters in patients with lung cancer undergoing CTX. Most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

Original languageEnglish (US)
JournalJournal of Pain and Symptom Management
DOIs
StatePublished - Jan 1 2019

Fingerprint

Lung Neoplasms
Drug Therapy
Illness Behavior
Symptom Assessment
Statistical Factor Analysis
Psychology
Research

Keywords

  • chemotherapy
  • exploratory factor analysis
  • lung cancer
  • symptom clusters
  • symptom occurrence
  • symptom severity
  • Symptoms

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy. / Russell, Jacquelyn; Wong, Melisa L.; Mackin, Lynda; Paul, Steven M.; Cooper, Bruce A.; Hammer, Marilyn; Conley, Yvette P.; Wright, Fay; Levine, Jon D.; Miaskowski, Christine.

In: Journal of Pain and Symptom Management, 01.01.2019.

Research output: Contribution to journalArticle

Russell, Jacquelyn ; Wong, Melisa L. ; Mackin, Lynda ; Paul, Steven M. ; Cooper, Bruce A. ; Hammer, Marilyn ; Conley, Yvette P. ; Wright, Fay ; Levine, Jon D. ; Miaskowski, Christine. / Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy. In: Journal of Pain and Symptom Management. 2019.
@article{db52def72cdd48f0876f0bed7593b170,
title = "Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy",
abstract = "Context: Patients with lung cancer who undergo chemotherapy (CTX) experience multiple symptoms. Evaluation of how these symptoms cluster together and how these symptom clusters change over time are salient questions in symptom clusters research. Objectives: The purposes of this analysis, in a sample of patients with lung cancer (n = 145) who were receiving CTX, were to 1) evaluate for differences in the number and types of symptom clusters at three time points (i.e., before their next cycle of CTX, the week after CTX, and two weeks after CTX) using ratings of symptom occurrence and severity and 2) evaluate for changes in these symptom clusters over time. Methods: At each assessment, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, six distinct symptom clusters were identified; however, only three of these clusters (i.e., lung cancer specific, psychological, nutritional) were relatively stable across both dimensions and across time. Two additional clusters varied by time but not by symptom dimension (i.e., epithelial/gastrointestinal and epithelial). A sickness behavior cluster was identified at each assessment with the exception of the week before CTX using only the severity dimension. Conclusion: Findings provide insights into the most common symptom clusters in patients with lung cancer undergoing CTX. Most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.",
keywords = "chemotherapy, exploratory factor analysis, lung cancer, symptom clusters, symptom occurrence, symptom severity, Symptoms",
author = "Jacquelyn Russell and Wong, {Melisa L.} and Lynda Mackin and Paul, {Steven M.} and Cooper, {Bruce A.} and Marilyn Hammer and Conley, {Yvette P.} and Fay Wright and Levine, {Jon D.} and Christine Miaskowski",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jpainsymman.2019.02.002",
language = "English (US)",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy

AU - Russell, Jacquelyn

AU - Wong, Melisa L.

AU - Mackin, Lynda

AU - Paul, Steven M.

AU - Cooper, Bruce A.

AU - Hammer, Marilyn

AU - Conley, Yvette P.

AU - Wright, Fay

AU - Levine, Jon D.

AU - Miaskowski, Christine

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Context: Patients with lung cancer who undergo chemotherapy (CTX) experience multiple symptoms. Evaluation of how these symptoms cluster together and how these symptom clusters change over time are salient questions in symptom clusters research. Objectives: The purposes of this analysis, in a sample of patients with lung cancer (n = 145) who were receiving CTX, were to 1) evaluate for differences in the number and types of symptom clusters at three time points (i.e., before their next cycle of CTX, the week after CTX, and two weeks after CTX) using ratings of symptom occurrence and severity and 2) evaluate for changes in these symptom clusters over time. Methods: At each assessment, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, six distinct symptom clusters were identified; however, only three of these clusters (i.e., lung cancer specific, psychological, nutritional) were relatively stable across both dimensions and across time. Two additional clusters varied by time but not by symptom dimension (i.e., epithelial/gastrointestinal and epithelial). A sickness behavior cluster was identified at each assessment with the exception of the week before CTX using only the severity dimension. Conclusion: Findings provide insights into the most common symptom clusters in patients with lung cancer undergoing CTX. Most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

AB - Context: Patients with lung cancer who undergo chemotherapy (CTX) experience multiple symptoms. Evaluation of how these symptoms cluster together and how these symptom clusters change over time are salient questions in symptom clusters research. Objectives: The purposes of this analysis, in a sample of patients with lung cancer (n = 145) who were receiving CTX, were to 1) evaluate for differences in the number and types of symptom clusters at three time points (i.e., before their next cycle of CTX, the week after CTX, and two weeks after CTX) using ratings of symptom occurrence and severity and 2) evaluate for changes in these symptom clusters over time. Methods: At each assessment, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, six distinct symptom clusters were identified; however, only three of these clusters (i.e., lung cancer specific, psychological, nutritional) were relatively stable across both dimensions and across time. Two additional clusters varied by time but not by symptom dimension (i.e., epithelial/gastrointestinal and epithelial). A sickness behavior cluster was identified at each assessment with the exception of the week before CTX using only the severity dimension. Conclusion: Findings provide insights into the most common symptom clusters in patients with lung cancer undergoing CTX. Most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

KW - chemotherapy

KW - exploratory factor analysis

KW - lung cancer

KW - symptom clusters

KW - symptom occurrence

KW - symptom severity

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=85062881519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062881519&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2019.02.002

DO - 10.1016/j.jpainsymman.2019.02.002

M3 - Article

C2 - 30768960

AN - SCOPUS:85062881519

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

ER -